Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Covid-19: risk factors for severe disease and death.

Jordan RE, Adab P, Cheng KK.

BMJ. 2020 Mar 26;368:m1198. doi: 10.1136/bmj.m1198. No abstract available.

PMID:
32217618
2.

Work productivity loss among rheumatoid arthritis patients in India: a qualitative study.

Jain A, Aggarwal A, Adams J, Jordan RE, Sadhra S, Dubey S, Allen K, Kumar K.

Rheumatol Adv Pract. 2019 Nov 20;3(2):rkz046. doi: 10.1093/rap/rkz046. eCollection 2019.

3.

Referral of patients with chronic obstructive pulmonary disease to pulmonary rehabilitation: a qualitative study of barriers and enablers for primary healthcare practitioners.

Watson JS, Adab P, Jordan RE, Enocson A, Greenfield S.

Br J Gen Pract. 2020 Mar 26;70(693):e274-e284. doi: 10.3399/bjgp20X708101. Print 2020 Apr.

PMID:
31988083
4.

Accuracy of Vitalograph lung monitor as a screening test for COPD in primary care.

Dickens AP, Fitzmaurice DA, Adab P, Sitch A, Riley RD, Enocson A, Jordan RE.

NPJ Prim Care Respir Med. 2020 Jan 3;30(1):2. doi: 10.1038/s41533-019-0158-2.

5.

External Validation Of The Updated ADO Score In COPD Patients From The Birmingham COPD Cohort.

Keene SJ, Jordan RE, Franssen FM, de Vries F, Martin J, Sitch A, Turner AM, Dickens AP, Fitzmaurice D, Adab P.

Int J Chron Obstruct Pulmon Dis. 2019 Oct 24;14:2395-2407. doi: 10.2147/COPD.S212381. eCollection 2019.

6.

Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care.

Lambe T, Adab P, Jordan RE, Sitch A, Enocson A, Jolly K, Marsh J, Riley R, Miller M, Cooper BG, Turner AM, Ayres JG, Stockley R, Greenfield S, Siebert S, Daley A, Cheng KK, Fitzmaurice D, Jowett S.

Thorax. 2019 Aug;74(8):730-739. doi: 10.1136/thoraxjnl-2018-212148. Epub 2019 Jul 8.

7.

Systematic review of the effectiveness of community-based self-management interventions among primary care COPD patients.

Jolly K, Sidhu MS, Bates E, Majothi S, Sitch A, Bayliss S, Kim HJS, Jordan RE.

NPJ Prim Care Respir Med. 2018 Nov 23;28(1):44. doi: 10.1038/s41533-018-0111-9.

8.

Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapy.

Jordan RE, Fan X, Salazar G, Zhang N, An Z.

Oncoimmunology. 2018 Jul 23;7(9):e1480300. doi: 10.1080/2162402X.2018.1480300. eCollection 2018. Review.

9.

Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial.

Miller MR, Haroon S, Jordan RE, Sitch AJ, Dickens AP, Enocson A, Fitzmaurice DA, Adab P.

Int J Chron Obstruct Pulmon Dis. 2018 Jun 21;13:1979-1986. doi: 10.2147/COPD.S146914. eCollection 2018.

10.

Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo.

Hsiao HC, Fan X, Jordan RE, Zhang N, An Z.

Breast Cancer Res. 2018 Jun 1;20(1):43. doi: 10.1186/s13058-018-0972-4.

11.

Case-finding for COPD in primary care: a qualitative study of patients' perspectives.

Enocson A, Jolly K, Jordan RE, Fitzmaurice DA, Greenfield SM, Adab P.

Int J Chron Obstruct Pulmon Dis. 2018 May 17;13:1623-1632. doi: 10.2147/COPD.S147718. eCollection 2018.

12.

Systematic review: chronic obstructive pulmonary disease and work-related outcomes.

Rai KK, Adab P, Ayres JG, Jordan RE.

Occup Med (Lond). 2018 Mar 27;68(2):99-108. doi: 10.1093/occmed/kqy012.

PMID:
29528460
13.

Independent determinants of disease-related quality of life in COPD - scope for nonpharmacologic interventions?

Brien SB, Stuart B, Dickens AP, Kendrick T, Jordan RE, Adab P, Thomas M.

Int J Chron Obstruct Pulmon Dis. 2018 Jan 9;13:247-256. doi: 10.2147/COPD.S152955. eCollection 2018.

14.

Factors associated with work productivity among people with COPD: Birmingham COPD Cohort.

Rai KK, Adab P, Ayres JG, Siebert WS, Sadhra SS, Sitch AJ, Fitzmaurice DA, Jordan RE; BLISS research team*.

Occup Environ Med. 2017 Dec;74(12):859-867. doi: 10.1136/oemed-2016-104014. Epub 2017 Sep 12.

PMID:
28899966
15.
16.

Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score.

Haroon S, Adab P, Riley RD, Fitzmaurice D, Jordan RE.

Eur Respir J. 2017 Jun 22;49(6). pii: 1602191. doi: 10.1183/13993003.02191-2016. Print 2017 Jun.

17.

Birmingham COPD Cohort: a cross-sectional analysis of the factors associated with the likelihood of being in paid employment among people with COPD.

Rai KK, Jordan RE, Siebert WS, Sadhra SS, Fitzmaurice DA, Sitch AJ, Ayres JG, Adab P.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 11;12:233-242. doi: 10.2147/COPD.S119467. eCollection 2017.

18.

Results of the 2015 Perfusionist Salary Study.

Lewis DM, Dove S, Jordan RE.

J Extra Corpor Technol. 2016 Dec;48(4):179-187.

19.

Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?

Man WD, Puhan MA, Harrison SL, Jordan RE, Quint JK, Singh SJ.

ERJ Open Res. 2015 Oct 6;1(2). pii: 00050-2015. eCollection 2015 Oct.

20.

COPD case finding: effective, but also cost-effective? - Authors' reply.

Jordan RE, Jowett S, Fitzmaurice D, Adab P; Birmingham Lung Improvement Study (BLISS) Research team.

Lancet Respir Med. 2016 Oct;4(10):e50. doi: 10.1016/S2213-2600(16)30267-3. No abstract available.

PMID:
27707466
21.

The effect of domiciliary noninvasive ventilation on clinical outcomes in stable and recently hospitalized patients with COPD: a systematic review and meta-analysis.

Dretzke J, Moore D, Dave C, Mukherjee R, Price MJ, Bayliss S, Wu X, Jordan RE, Turner AM.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 16;11:2269-2286. eCollection 2016. Review.

22.

Tumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector function.

Zhang N, Jordan RE, An Z.

Oncoimmunology. 2015 Dec 29;5(5):e1122861. doi: 10.1080/2162402X.2015.1122861. eCollection 2016 May.

23.

Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial.

Jordan RE, Adab P, Sitch A, Enocson A, Blissett D, Jowett S, Marsh J, Riley RD, Miller MR, Cooper BG, Turner AM, Jolly K, Ayres JG, Haroon S, Stockley R, Greenfield S, Siebert S, Daley AJ, Cheng KK, Fitzmaurice D.

Lancet Respir Med. 2016 Sep;4(9):720-730. doi: 10.1016/S2213-2600(16)30149-7. Epub 2016 Jul 19.

PMID:
27444687
24.

Cohort Profile: The Birmingham Chronic Obstructive Pulmonary Disease (COPD) Cohort Study.

Adab P, Fitzmaurice DA, Dickens AP, Ayres JG, Buni H, Cooper BG, Daley AJ, Enocson A, Greenfield S, Jolly K, Jowett S, Kalirai K, Marsh JL, Miller MR, Riley RD, Siebert WS, Stockley RA, Turner AM, Cheng KK, Jordan RE.

Int J Epidemiol. 2017 Feb 1;46(1):23. doi: 10.1093/ije/dyv350. No abstract available.

PMID:
27378796
25.

Self-management of health care behaviors for COPD: a systematic review and meta-analysis.

Jolly K, Majothi S, Sitch AJ, Heneghan NR, Riley RD, Moore DJ, Bates EJ, Turner AM, Bayliss SE, Price MJ, Singh SJ, Adab P, Fitzmaurice DA, Jordan RE.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 17;11:305-26. doi: 10.2147/COPD.S90812. eCollection 2016. Review.

26.

A peptide immunization approach to counteract a Staphylococcus aureus protease defense against host immunity.

Jordan RE, Fernandez J, Brezski RJ, Greenplate AR, Knight DM, Raju TS, Lynch AS.

Immunol Lett. 2016 Apr;172:29-39. doi: 10.1016/j.imlet.2016.02.009. Epub 2016 Feb 18.

PMID:
26905931
27.

Case finding for COPD in primary care: a qualitative study of the views of health professionals.

Haroon S, Jordan RE, Fitzmaurice DA, Adab P.

Int J Chron Obstruct Pulmon Dis. 2015 Aug 28;10:1711-8. doi: 10.2147/COPD.S84247. eCollection 2015.

28.

Effectiveness of case finding strategies for COPD in primary care: a systematic review and meta-analysis.

Haroon SM, Jordan RE, O'Beirne-Elliman J, Adab P.

NPJ Prim Care Respir Med. 2015 Aug 27;25:15056. doi: 10.1038/npjpcrm.2015.56. Review.

29.

Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease.

Biancheri P, Brezski RJ, Di Sabatino A, Greenplate AR, Soring KL, Corazza GR, Kok KB, Rovedatti L, Vossenkämper A, Ahmad N, Snoek SA, Vermeire S, Rutgeerts P, Jordan RE, MacDonald TT.

Gastroenterology. 2015 Nov;149(6):1564-1574.e3. doi: 10.1053/j.gastro.2015.07.002. Epub 2015 Jul 11.

30.

Supported self-management for patients with COPD who have recently been discharged from hospital: a systematic review and meta-analysis.

Majothi S, Jolly K, Heneghan NR, Price MJ, Riley RD, Turner AM, Bayliss SE, Moore DJ, Singh SJ, Adab P, Fitzmaurice DA, Jordan RE.

Int J Chron Obstruct Pulmon Dis. 2015 Apr 29;10:853-67. doi: 10.2147/COPD.S74162. eCollection 2015. Review.

31.

Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.

Jordan RE, Majothi S, Heneghan NR, Blissett DB, Riley RD, Sitch AJ, Price MJ, Bates EJ, Turner AM, Bayliss S, Moore D, Singh S, Adab P, Fitzmaurice DA, Jowett S, Jolly K.

Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360. Review.

32.

An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.

Kinder M, Greenplate AR, Strohl WR, Jordan RE, Brezski RJ.

MAbs. 2015;7(3):494-504. doi: 10.1080/19420862.2015.1022692.

33.

Predicting risk of COPD in primary care: development and validation of a clinical risk score.

Haroon S, Adab P, Riley RD, Marshall T, Lancashire R, Jordan RE.

BMJ Open Respir Res. 2015 Mar 27;2(1):e000060. doi: 10.1136/bmjresp-2014-000060. eCollection 2015.

34.

Trastuzumab triggers phagocytic killing of high HER2 cancer cells in vitro and in vivo by interaction with Fcγ receptors on macrophages.

Shi Y, Fan X, Deng H, Brezski RJ, Rycyzyn M, Jordan RE, Strohl WR, Zou Q, Zhang N, An Z.

J Immunol. 2015 May 1;194(9):4379-86. doi: 10.4049/jimmunol.1402891. Epub 2015 Mar 20.

35.

A novel therapeutic strategy to rescue the immune effector function of proteolytically inactivated cancer therapeutic antibodies.

Fan X, Brezski RJ, Deng H, Dhupkar PM, Shi Y, Gonzalez A, Zhang S, Rycyzyn M, Strohl WR, Jordan RE, Zhang N, An Z.

Mol Cancer Ther. 2015 Mar;14(3):681-91. doi: 10.1158/1535-7163.MCT-14-0715. Epub 2014 Dec 31.

36.

A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.

Brezski RJ, Kinder M, Grugan KD, Soring KL, Carton J, Greenplate AR, Petley T, Capaldi D, Brosnan K, Emmell E, Watson S, Jordan RE.

MAbs. 2014;6(5):1265-73. doi: 10.4161/mabs.29825. Epub 2014 Oct 30.

37.

TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care: protocol.

Jordan RE, Adab P, Jowett S, Marsh JL, Riley RD, Enocson A, Miller MR, Cooper BG, Turner AM, Ayres JG, Cheng KK, Jolly K, Stockley RA, Greenfield S, Siebert S, Daley A, Fitzmaurice DA.

BMC Pulm Med. 2014 Oct 4;14:157. doi: 10.1186/1471-2466-14-157.

38.

Structure and specificity of an antibody targeting a proteolytically cleaved IgG hinge.

Malia TJ, Teplyakov A, Brezski RJ, Luo J, Kinder M, Sweet RW, Almagro JC, Jordan RE, Gilliland GL.

Proteins. 2014 Aug;82(8):1656-67. doi: 10.1002/prot.24545. Epub 2014 Apr 16.

PMID:
24638881
39.

Engineered protease-resistant antibodies with selectable cell-killing functions.

Kinder M, Greenplate AR, Grugan KD, Soring KL, Heeringa KA, McCarthy SG, Bannish G, Perpetua M, Lynch F, Jordan RE, Strohl WR, Brezski RJ.

J Biol Chem. 2013 Oct 25;288(43):30843-54. doi: 10.1074/jbc.M113.486142. Epub 2013 Aug 28.

40.

Factors Affecting Acceptance and Intention to Receive Pandemic Influenza A H1N1 Vaccine among Primary School Children: A Cross-Sectional Study in Birmingham, UK.

Janks M, Cooke S, Odedra A, Kang H, Bellman M, Jordan RE.

Influenza Res Treat. 2012;2012:182565. doi: 10.1155/2012/182565. Epub 2012 Oct 17.

41.

Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function.

Grugan KD, McCabe FL, Kinder M, Greenplate AR, Harman BC, Ekert JE, van Rooijen N, Anderson GM, Nemeth JA, Strohl WR, Jordan RE, Brezski RJ.

J Immunol. 2012 Dec 1;189(11):5457-66. doi: 10.4049/jimmunol.1201889. Epub 2012 Oct 26.

42.

A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy.

Fan X, Brezski RJ, Fa M, Deng H, Oberholtzer A, Gonzalez A, Dubinsky WP, Strohl WR, Jordan RE, Zhang N, An Z.

Breast Cancer Res. 2012 Aug 8;14(4):R116. doi: 10.1186/bcr3240.

43.

Case finding for COPD in primary care: a systematic review.

Haroon SM, Adab PA, Jordan RE.

Prim Care Respir J. 2012 Sep;21(3):354-7. doi: 10.4104/pcrj.2012.00060. Review. No abstract available.

44.

Manual therapy for chronic obstructive airways disease: a systematic review of current evidence.

Heneghan NR, Adab P, Balanos GM, Jordan RE.

Man Ther. 2012 Dec;17(6):507-18. doi: 10.1016/j.math.2012.05.004. Epub 2012 Jun 15. Review.

PMID:
22703901
45.

Galactosylation variations in marketed therapeutic antibodies.

Raju TS, Jordan RE.

MAbs. 2012 May-Jun;4(3):385-91. doi: 10.4161/mabs.19868. Epub 2012 Apr 26.

46.

Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Analysis of the Health Survey for England.

Jordan RE, Miller MR, Lam KB, Cheng KK, Marsh J, Adab P.

Thorax. 2012 Jul;67(7):600-5. doi: 10.1136/thoraxjnl-2011-201384. Epub 2012 Mar 1.

PMID:
22382600
47.

The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge.

Brezski RJ, Oberholtzer A, Strake B, Jordan RE.

MAbs. 2011 Nov-Dec;3(6):558-67. doi: 10.4161/mabs.3.6.18119. Epub 2011 Nov 1.

48.

Passive smoking and chronic obstructive pulmonary disease: cross-sectional analysis of data from the Health Survey for England.

Jordan RE, Cheng KK, Miller MR, Adab P.

BMJ Open. 2011 Jan 1;1(2):e000153. doi: 10.1136/bmjopen-2011-000153.

50.

The origins, specificity, and potential biological relevance of human anti-IgG hinge autoantibodies.

Brezski RJ, Knight DM, Jordan RE.

ScientificWorldJournal. 2011 May 26;11:1153-67. doi: 10.1100/tsw.2011.107. Review.

Supplemental Content

Loading ...
Support Center